Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2 | P10415 | 20/20 | 0.58 |
| ▸ | BCL2L1 | Q07817 | 6/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30538255 | 0.97 | BCL2 (0.57) | BCL2BCL2L1 | |
| SCHEMBL29796253 | 0.94 | BCL2 (0.58) | BCL2BCL2L1 | |
| SCHEMBL29796312 | 0.91 | BCL2 (0.61) | BCL2BCL2L1 | |
| SCHEMBL2724229 | 0.91 | BCL2 (0.61) | BCL2BCL2L1 | |
| SCHEMBL30314189 | 0.90 | BCL2 (0.56) | BCL2BCL2L1 | |
| SCHEMBL2724836 | 0.90 | BCL2 (0.55) | BCL2BCL2L1 | |
| SCHEMBL30313888 | 0.90 | BCL2 (0.55) | BCL2BCL2L1 | |
| SCHEMBL29657441 | 0.90 | BCL2 (0.60) | BCL2BCL2L1 | |
| SCHEMBL2725532 | 0.90 | BCL2 (0.65) | BCL2BCL2L1 | |
| SCHEMBL29657428 | 0.90 | BCL2 (0.65) | BCL2BCL2L1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4682148-A2 | APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES | AbbVie Ireland Unlimited Company (IE) | 2026-01-21 | — | — | EP | disclosed |
| CN-114786679-A | Combination therapy with Vernetork and TIM-3 inhibitors | 诺华股份有限公司 | 2022-07-22 | — | — | CN | disclosed |
| CN-114786680-A | TIM-3 inhibitors and uses thereof | 诺华股份有限公司 | 2022-07-22 | — | — | CN | disclosed |